Bech-Bruun

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Gold - Firms: litigation and transactions

A premier destination for major pharmaceutical companies embroiled in hard-hitting disputes, Bech-Bruun is committed to winning and has all the firepower needed to prevail when everything is on the line. Recent storylines include assisting Samsung Bioepis in novel biosimilar preliminary injunction proceedings; and acting for Sandoz in spats against AstraZeneca and Eli Lilly. Taking centre stage on all three is Klaus Ewald Madsen, who has earned the utmost respect of peers. “This is prime time for Klaus,” enthuses one peer. “He is absolutely brilliant and rightfully attracts an immense workload.” Co-head of the life sciences group is the “brilliant and widely renowned” Martin Draebye Gantzhorn. He adds tremendous value with his rich regulatory knowledge and can see through convoluted healthcare cases with crystalline clarity. Johnny Petersen is another seasoned trial hand whose compelling arguments and strategic insight frequently make the difference. The firm has an exceptionally potent renewable energy practice courtesy of Dan Bjerg Geary, who successfully defended KK Wind Solutions in infringement proceedings brought by GLX Power Systems. His negotiation skills are silky smooth and have sealed many a lucrative deal too. Søren Chr Søborg Andersen has a flair for the fine print of contracts at the confluence of IP, competition and regulatory law. He is the name to note for heavy-duty M&A transactions.

Get unlimited access to all IAM content